API development – Page 7 – Pharma Made Easy

Crystalline vs Amorphous Drugs in Pharma: Key Differences, Benefits, and Risks

Crystalline vs Amorphous Drugs in Pharma: Key Differences, Benefits, and Risks Understanding the Differences Between Crystalline and Amorphous Drugs in Pharmaceuticals Solid state properties in pharma play a crucial role in drug development, influencing bioavailability, stability, and manufacturing processes. This…

Solid State Properties

Polymorphism in Pharmaceuticals: Impact on Solubility, Stability, and Bioavailability

Polymorphism in Pharmaceuticals: Impact on Solubility, Stability, and Bioavailability The Role of Polymorphism in Pharmaceuticals: Effects on Solubility, Stability, and Bioavailability Polymorphism is a vital concept in the pharmaceutical industry, significantly affecting the solid state properties in pharma. It refers…

Solid State Properties

Solid State Properties in Pharma: Why Crystal Form Matters in Drug Development

Solid State Properties in Pharma: Why Crystal Form Matters in Drug Development The Importance of Solid State Properties in Pharmaceutical Development: Understanding Crystal Form In the pharmaceutical industry, the solid state properties of drug substances play a critical role in…

Crystallization and Purification

Crystallization and Purification in Pharma: Complete Guide for Pharmaceutical Professionals

Crystallization and Purification in Pharma: Complete Guide for Pharmaceutical Professionals A Comprehensive Guide to Crystallization and Purification in the Pharmaceutical Industry The pharmaceutical sector heavily relies on the principles of crystallization and purification in API (Active Pharmaceutical Ingredient) development and…